SCHEMBL22010460

SCHEMBL22010460

N=C(Cc1ccc(-c2ccc(Cl)cc2)cc1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTBP2 P56545 1/20 0.51
L3MBTL1 Q9Y468 3/20 0.47
TDP1 Q9NUW8 1/20 0.47
LMNA P02545 2/20 0.46
ABCC4 O15439 1/20 0.46
GAA P10253 1/20 0.46
TSHR P16473 1/20 0.46
PTGS1 P23219 1/20 0.46
HTT P42858 1/20 0.46
MAPT P10636 2/20 0.44
PPARA Q07869 4/20 0.44
PPARG P37231 3/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
ERCC5 P28715 1/20 0.43
FEN1 P39748 1/20 0.43
ADAMTS5 Q9UNA0 1/20 0.42
PIK3CA P42336 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22010059 0.82 FFAR1 (0.49) MEN1KMT2A
SCHEMBL4211639 0.80 ABCC4 (0.69) CTBP2L3MBTL1TDP1LMNAABCC4
SCHEMBL4808967 0.78 CTBP2 (0.51) CTBP2L3MBTL1TDP1LMNAABCC4
SCHEMBL22331603 0.76 CA2 (0.61) CTBP2LMNANPC1RAB9A
SCHEMBL9621531 0.76 CES1 (0.58) CTBP2L3MBTL1TDP1LMNAABCC4
SCHEMBL7151264 0.75 NPC1 (0.50) CTBP2L3MBTL1LMNAABCC4GAA
SCHEMBL13205252 0.75 CTBP2 (0.56) CTBP2L3MBTL1TDP1LMNAGAA
SCHEMBL15338388 0.75 NPC1 (0.47) CTBP2L3MBTL1TDP1LMNAABCC4
SCHEMBL12809543 0.75 CA2 (0.57) CTBP2L3MBTL1LMNAABCC4GAA
SCHEMBL16478469 0.75 F2 (0.43) CTBP2LMNAABCC4GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200157144-A1 ANTIMICROBIAL PEPTIDOMIMETICS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200157144-A1 ANTIMICROBIAL PEPTIDOMIMETICS NGLY1, GLMN, GMPS CTBP2 1032/4885L3MBTL1 473/4885TDP1 2426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.